Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 3Unknown 2Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1FED 1

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 78Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Leukemia, Lymphocytic, Chronic, B-Cell 70Myelodysplastic Syndromes 64Hodgkin Disease 63Multiple Myeloma 59Lymphoma, Non-Hodgkin 58Leukemia 53Lymphoma, Follicular 44Lymphoma, Mantle-Cell 43Lymphoma, Large B-Cell, Diffuse 41Lymphoma 41Myeloproliferative Disorders 39Lymphoma, B-Cell, Marginal Zone 37Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37Leukemia, Myeloid, Chronic-Phase 35Congenital Abnormalities 35Burkitt Lymphoma 33Lymphoma, Large-Cell, Immunoblastic 30Leukemia, Myelomonocytic, Chronic 29Leukemia, Myeloid, Accelerated Phase 27Waldenstrom Macroglobulinemia 25Anemia, Refractory, with Excess of Blasts 25Hematologic Neoplasms 23Graft vs Host Disease 21Recurrence 20Dendritic Cell Sarcoma, Interdigitating 20Primary Myelofibrosis 19Lymphoma, T-Cell, Cutaneous 19Blast Crisis 19

Interventions

rozanolixizumab 5zilucoplan 4eculizumab 4Rituximab 4Immunoglobulins, Intravenous 4efgartigimod alfa 3Tacrolimus 3Mycophenolic Acid 3Hizentra 3HBM9161 3Data Collection 2Azathioprine 2tofacitinib 1telitacicept 1ravulizumab 1iscalimab 1gamma-Globulins 1apraclonidine 1Thymectomy 1Telemedicine 1Sugammadex 1Sodium Chloride 1Pyridostigmine Bromide 1Prednisone 1Prednisolone 1Plasmapheresis 1Plasma Exchange 1Neurofeedback 1Neostigmine 1Muscle Stretching Exercises 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Myasthenia Gravis × Mycophenolic Acid × Clear all
NCT03490539 2021-02-03

PROMISE-MG

Duke University

Completed
167 enrolled

Autoimmune Diseases, Myasthenia Gravis, Nervous System Diseases

NCT00285350 2015-03-25

Mycophenolate Mofetil in Myasthenia Gravis

FDA Office of Orphan Products Development

Phase 3 Completed
80 enrolled

Myasthenia Gravis

NCT00683969 2008-05-26

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

Hoffmann-La Roche

Phase 3 Completed
136 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡